From carrying out significant strategies to making a mark in the healthcare industry through his experience of 30 years, Kåre Schultz has been appointed as the new face of the company.
Kåre Schultz is the new President & Chief Executive Officer of Teva Pharmaceutical Industries.
(Source: Teva Pharmaceutical Industries)
Jerusalem/Israel — Teva Pharmaceutical Industries has recently announced that its Board of Directors has named Kåre Schultz to become the company’s President and Chief Executive Officer. Schultz will succeed Dr. Yitzhak Peterburg, who will continue to serve as Interim Chief Executive Officer until Schultz joins the company.
The leadership announcement represents the successful completion of the global search process to identify the best leader for the company and was executed by the Teva Board of Directors, with the assistance of Heidrick & Struggles. Schultz will be relocating to Israel.
Schultz is a seasoned veteran in the healthcare industry with a distinguished, nearly thirty year career across various global pharmaceutical and healthcare companies. Over the course of his career, he has developed a unique perspective overseeing generic and specialty drug portfolios, while managing complex business operations around the world.
He most recently served as the President and Chief Executive Officer of H. Lundbeck A/S, where he is credited with leading significant restructuring initiatives and also launching a robust turnaround strategy focused on driving a sustainable global cost structure and operational model.
Stand vom 23.03.2021
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planckstr. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://support.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.